US FDA completes inspection at Alkem’s Baddi facility

hanuman

Active member
FDA-GREEN-1.jpg


Alkem Laboratories announced the completion of the inspection at its manufacturing facility in Baddi, Himachal Pradesh. The United States Food and Drug Administration (US FDA) issued an Establishment Inspection Report (EIR) for the manufacturing facility.

The Inspection was classified as Voluntary Action Indicated (VAI), following which the inspection was properly closed The establishment was examined by the US FDA on March 27, 2024.

The post appeared first on .
 
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock